!!María-Victoria Mateos - Biography
\\
Dr. María-Victoria Mateos, MD, PhD, is Head of Myeloma and clinical trials Unit at the Haematology Department and Professor of Medicine at the University of Salamanca, Spain. \\
\\
She serves as chair of GEM (Spanish Myeloma Group), with direct involvement in the design and development of clinical trials. She has coordinated many clinical trials especially in the setting of transplant ineligible and smoldering myeloma and these trials have profoundly influenced current options for the management of these patient populations. \\
\\
María-Victoria Mateos has published over 450 papers in international journals with an H index of 105. \\
\\
María-Victoria Mateos is also a member of the IMWG (International MM Working Group) scientific board as well of  IMS (International MM Society) executive board. She is also an active member of EHA and ASH. \\
\\
María-Victoria Mateos has served on the ASH Scientific Committee on plasma cell diseases between 2015 - 2019 and on the EHA’s Scientific Program Committee and Advisory Board since 2013 until 2020 being chair of the Scientific Program Committee in 2019. She has been Councillor on the EHA Board since 2015 for a four-year mandate, member of the European School of Haematology (ESH) Scientific committee and member of the ASCO scientific program committee. \\
\\
María-Victoria Mateos is the President of the National Society of Hematology since October 2022 for a four-year mandate.\\ \\[{ALLOW view All}][{ALLOW edit mmateos}][{ALLOW upload mmateos}][{ALLOW comment All}]